New Marker Identified for Breast Cancer Metastasis
An estimated 40 percent of all breast cancer patients relapse and develop metastatic disease. Traditionally, the likelihood of breast cancer metastasis is estimated based on tumor size, tumor differentiation -- how similar or dissimilar the tumor is compared to normal breast tissue -- and whether the cancer has spread to the lymph nodes. TMEM density may prove to be more determinative of the likelihood of breast cancer metastatis than these traditional measures.
If your breast cancer was missed or misdiagnosed, see the breast cancer malpractice lawyers of Pennsylvania. Berger & Lagnese is a law firm that specializes in breast cancer medical malpractice cases. We work on cases in Pittsburgh and all over Western Pennsylvania, including Greensburg, Washington, Uniontown, Beaver, and Erie.